Ventripoint Diagnostics Announces U.S. FDA 510(k) Clearance for VMS+(TM) 4.0 Automated Radiological Image Processing Software/System

Stock Information for Ventripoint Diagnostics Ltd

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Ventripoint Diagnostics Ltd

Ventripoint Partners with Fournel Advisory
Ventripoint Issues Option Grants and Reports Exercise of Options
Ventripoint to Exhibit at the 58th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
Ventripoint Expands Advisory Board with addition of Ultrasound AI Executive
Ventripoint Provides Corporate Update and Announces Shareholder Teleconference
Ventripoint Appoints Nicolas Coutin to Oversee Clinical Affairs
Ventripoint Makes Application to Amend Warrants
Ventripoint Diagnostics Publishes Whitepaper on the Use of AI in Whole-Heart Analysis

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.